Drug
Danicopan
Danicopan: highest development phase Phase 2, developed by Alexion. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| Danicopan NCT03053102 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Danicopan NCT04935294 | Phase 1 | Healthy |
Latest
No recent events.
Follow Danicopan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.